Australia Animal Diagnostics Market Overview, 2031

The Australian animal diagnostics market has shown steady performance, and the growth is driven by rising pet ownership, livestock disease management needs, and heightened awareness of zoonotic diseases. The diagnostics form a critical sub-sector supporting both companion animals and livestock industries. The purpose of diagnostics lies in early disease detection, prevention, and improved animal welfare, benefiting veterinarians, farmers, and pet owners alike. Historically, the market evolved from basic pathology and bacteriology tests to advanced molecular diagnostics, imaging systems, and point-of-care devices. Today, the scope of products spans immunodiagnostics, hematology, urinalysis, and biochemistry, while technology adoption includes AI-assisted imaging and portable diagnostic kits. Market components include veterinary clinics, diagnostic laboratories, universities, and home-care settings, each contributing to accessibility and innovation. Policies around biosecurity, animal welfare, and export standards shape the market, ensuring compliance with international trade and disease control. Challenges include high costs of advanced technologies, limited rural access, and the need for skilled professionals. Cultural trends such as the humanization of pets and consumer demand for premium animal-derived products influence customer behaviour, with owners increasingly seeking preventive care and rapid diagnostics. Future growth will likely be accelerated by digital platforms that integrate diagnostics with telemedicine. This convergence is expected to make veterinary care more accessible and cost-efficient across Australia. The market connects closely with the parent animal health sector, reinforcing livestock productivity and companion animal wellbeing, while aligning with broader healthcare trends in precision medicine and digital health. Moreover, sustainability initiatives are encouraging eco-friendly diagnostic practices, further shaping the industry’s long-term trajectory.

According to the research report, "Australia Animal Diagnostics Overview, 2031," published by Bonafide Research, the Australia Animal Diagnostics is anticipated to grow at more than 8.5% CAGR from 2026 to 2031.The competitive landscape of the Australian animal diagnostics market is moderately concentrated, with both global and local players contributing to growth. Local companies such as IDEXX Laboratories Australia, Gribbles Veterinary Pathology, Vetnostics, and ASAP Laboratory Services provide a range of diagnostic services including pathology, microbiology, molecular testing, and imaging. Their unique selling propositions (USPs) lie in rapid turnaround times, specialized veterinary expertise, and integration of advanced technologies like AI-assisted diagnostics and digital imaging. Business models vary: IDEXX focuses on bundled diagnostic solutions and subscription-based services for clinics, while Gribbles and Vetnostics operate through centralized laboratories offering tiered pricing for routine and specialized tests. Price ranges differ significantly, with basic blood tests costing AUD 50–100, while advanced molecular diagnostics or imaging can exceed AUD 300 depending on complexity. Market trends highlight increasing demand for point-of-care diagnostics, telehealth integration, and portable devices for rural veterinary practices Mordor Intelligence. Opportunities lie in expanding companion animal diagnostics, particularly for cats and dogs, and leveraging AI-driven platforms to reduce diagnostic errors. The latest government-backed National Animal Health Diagnostics Business Plan emphasizes strengthening biosecurity, enhancing laboratory networks, and fostering innovation in diagnostic technologies. This policy framework creates opportunities for local players to collaborate with universities and research institutes, while also aligning with export-focused livestock industries. Customer behaviour trends show pet owners increasingly willing to pay for preventive diagnostics, while livestock producers prioritize cost-effective solutions that safeguard herd health and meet export standards. Future growth will likely be accelerated by digital platforms that integrate diagnostics with telemedicine. This convergence is expected to make veterinary care more accessible and cost-efficient across Australia.

The Australian animal diagnostics market, segmented by product type into molecular diagnostics, immunodiagnostics, and clinical biochemistry, which balances cutting-edge molecular tools with accessible immunoassays and routine biochemistry, ensuring comprehensive coverage across companion animals, livestock, and wildlife and also reflects the country’s growing emphasis on advanced veterinary healthcare and livestock biosecurity. In the molecular diagnostics segment, technologies such as PCR, DNA sequencing, and microarrays are increasingly adopted to detect infectious diseases, genetic disorders, and zoonotic pathogens with high accuracy. Australia’s livestock industry relies heavily on these tools to safeguard exports by ensuring early detection of diseases like avian influenza or bovine tuberculosis. Companion animal care also benefits, as molecular diagnostics enable veterinarians to identify hereditary conditions and tailor treatments, aligning with cultural trends of treating pets as family members. The immunodiagnostics segment encompasses ELISA assays, rapid test kits, and serological methods, widely used for routine screening of viral and bacterial infections. In Australia, immunodiagnostics are critical for monitoring herd health, vaccination efficacy, and disease surveillance programs. Their affordability and ease of use make them popular in both rural veterinary practices and large-scale livestock operations. Growing demand for point-of-care immunoassays reflects customer behaviour favouring quick, reliable, and cost-effective diagnostic solutions. Clinical biochemistry diagnostics focus on analysing blood, urine, and tissue samples to assess organ function, metabolic disorders, and nutritional deficiencies. In Australia, this segment is expanding in companion animal clinics, where pet owners increasingly seek preventive health checkups. Livestock producers also use biochemistry tests to monitor productivity and detect subclinical diseases that could impact herd performance.

The Australian animal diagnostics market, segmented by animal type into companion animals, livestock, and aquaculture, reflects the country’s diverse veterinary and agricultural needs. This segmentation connects with the global market, where integrated diagnostic approaches across species are becoming essential for animal health, food safety, and sustainable production. In the companion animal segment, diagnostics are driven by rising pet ownership and cultural trends that treat pets as family members. Australians increasingly invest in preventive healthcare for dogs, cats, and exotic pets, fuelling demand for blood tests, molecular diagnostics, and imaging services. Veterinary clinics and diagnostic labs provide routine screenings for infectious diseases, genetic disorders, and wellness monitoring, with customer behaviour showing strong preference for rapid, accurate, and affordable diagnostic solutions. The livestock segment represents a critical component of the market, given Australia’s reliance on cattle, sheep, and poultry for domestic consumption and export. Diagnostics in this segment focus on biosecurity, disease surveillance, and productivity monitoring. Tools such as ELISA assays, PCR-based tests, and clinical biochemistry are widely used to detect conditions like bovine respiratory disease, mastitis, and parasitic infections. Government policies emphasize strict disease control to protect Australia’s global reputation in meat and dairy exports, making livestock diagnostics a cornerstone of national agricultural sustainability. In the aquaculture segment, diagnostics are increasingly important as Australia expands its fish and seafood production. Pathogen detection, water quality monitoring, and molecular assays are used to safeguard against bacterial and viral outbreaks that can devastate fish farms. With aquaculture contributing significantly to food security and exports, diagnostic technologies ensure healthy stock and compliance with international standards.

The Australian animal diagnostics market, segmented by end-user into veterinary hospitals & clinics, diagnostic laboratories, and research institutes & universities, highlights the diverse ecosystem supporting animal health and biosecurity. This ensures comprehensive coverage across companion animals, livestock, and aquaculture, while connecting with the global market where collaboration between clinics, labs, and universities is essential for advancing veterinary science. In veterinary hospitals and clinics, diagnostics are central to companion animal care, with growing demand for routine blood tests, imaging, molecular assays, and point-of-care kits. Rising pet ownership and cultural trends treating pets as family members drive clinics to invest in advanced diagnostic equipment, ensuring early detection of diseases and preventive healthcare. Customer behaviour shows strong preference for rapid, affordable, and accurate diagnostics, making clinics the frontline of veterinary services across urban and regional Australia. Diagnostic laboratories play a critical role in livestock and wildlife health, offering specialized testing for infectious diseases, toxicology, and genetic analysis. These labs provide high-throughput capabilities and advanced molecular diagnostics, supporting Australia’s strict biosecurity policies and export standards. Laboratories such as Vetpath and Gribbles Veterinary Pathology deliver tailored services for companion animals and livestock, ensuring rapid turnaround times and compliance with national disease surveillance programs. Research institutes and universities form the innovation backbone of the market, developing new diagnostic technologies and conducting epidemiological studies. Institutions like the University of Sydney and CSIRO collaborate with government and private labs to advance molecular diagnostics, immunoassays, and AI-driven platforms. Their role extends beyond service provision to training veterinary professionals and supporting national preparedness against emerging zoonotic threats.



Considered in this report
• Historic Year 2020
• Base Year 2025
• Estimated Year 2026
• Forecast Year 2031

Aspects covered in this report
• Australia Animal Diagnostics Market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Molecular Diagnostics
• Immunodiagnostics
• Clinical Biochemistry

By Animal Type
• Companion Animals
• Livestock
• Aquaculture

By End-User
• Veterinary Hospitals and Clinics
• Diagnostic Laboratories
• Research Institutes and Universities